• Date:
  • Time: 1:30pm - 2:30pm
  • Track: Clinical Practice
  • CME/CE: 1.0
  • Type: In-Person, Virtual

Sponsored by the Osteoporosis and Metabolic Bone Disease Special Interest Group 
Moderator: Cathleen S. Colón-Emeric, MD, MHS 
In light of the new clinical practice guidelines from the Bone Health and Osteoporosis Foundation and advances in pharmacotherapy, this program will support attendees in providing evidence-based fracture prevention for patients with osteoporosis. Learning Objectives: (1) describe mobility interventions and care models that improve bone health and reduce injurious falls in older adults; (2) appropriately prescribe osteoporosis treatment regimens in common clinical scenarios, based on their pharmacobiology, risks, and benefits; (3) describe the pitfalls of race-based decisions in selecting osteoporosis pharmacotherapy; (4) tailor osteoporosis treatment plans for patients with multimorbidity, including dementia and chronic kidney disease; and (5) list elements of, and tools promoting, shared decision making around fracture prevention options with older adults and their care partners. 

Mobility in Osteoporosis Management 
Sonja L. Rosen, MD 

Designing Rational Osteoporosis Medication Regimens 
Cathleen S. Colón-Emeric, MD, MHS 

Mind and Medical Complexity in Osteoporosis Treatment 
Joshua D. Niznik, PharmD, PhD 

Promoting Shared Decision Making on What “Matter Most” in Fracture Prevention 
Sarah D. Berry, MD, MPH